Cathy Gwin
Senior Director, Communications
NTI | bio hosted an event on Capitol Hill to discuss how Congress and other key decisionmakers can take action to provide necessary oversight to safeguard biotechnologies, without stifling innovation in the field.
A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.
NTI | bio supported the development of a new report from Stanford University’s Bio Policy & Leadership in Society Initiative that highlights the importance of sharing biosecurity and biosafety best practices for life science research.
NTI | bio experts contributed to the 9th Biological Weapons Convention Review Conference in Geneva.
NTI | bio partnered with Carnegie India as a "knowledge partner" for the 2022 Global Technology Summit and led two sessions on global biosecurity and biosafety.
Sign up for our newsletter to get the latest on nuclear and biological threats.